A detailed history of Geode Capital Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 961,341 shares of PRCT stock, worth $58.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
961,341
Previous 931,491 3.2%
Holding current value
$58.7 Million
Previous $39 Million 21.7%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$40.38 - $50.75 $1.21 Million - $1.51 Million
29,850 Added 3.2%
961,341 $47.5 Million
Q4 2023

Feb 13, 2024

BUY
$24.89 - $43.41 $2.22 Million - $3.88 Million
89,286 Added 10.6%
931,491 $39 Million
Q3 2023

Nov 13, 2023

BUY
$30.02 - $38.81 $3.87 Million - $5.01 Million
129,014 Added 18.09%
842,205 $27.6 Million
Q2 2023

Aug 11, 2023

BUY
$26.7 - $37.02 $3.19 Million - $4.42 Million
119,313 Added 20.09%
713,191 $25.2 Million
Q1 2023

May 15, 2023

BUY
$26.64 - $39.74 $869,662 - $1.3 Million
32,645 Added 5.82%
593,878 $16.9 Million
Q4 2022

Feb 13, 2023

BUY
$38.78 - $46.78 $1.29 Million - $1.55 Million
33,203 Added 6.29%
561,233 $23.3 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $6.72 Million - $11 Million
217,362 Added 69.97%
528,030 $21.9 Million
Q2 2022

Aug 12, 2022

BUY
$29.23 - $44.45 $4.06 Million - $6.18 Million
139,042 Added 81.01%
310,668 $10.2 Million
Q1 2022

May 13, 2022

BUY
$16.89 - $35.74 $193,322 - $409,080
11,446 Added 7.15%
171,626 $6.01 Million
Q4 2021

Feb 11, 2022

BUY
$24.6 - $46.29 $3.71 Million - $6.99 Million
150,952 Added 1635.8%
160,180 $4.01 Million
Q3 2021

Nov 12, 2021

BUY
$35.91 - $41.94 $331,377 - $387,022
9,228 New
9,228 $352,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.72B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.